208 related articles for article (PubMed ID: 17474152)
1. Adenosine closes the K+ channel KCa3.1 in human lung mast cells and inhibits their migration via the adenosine A2A receptor.
Duffy SM; Cruse G; Brightling CE; Bradding P
Eur J Immunol; 2007 Jun; 37(6):1653-62. PubMed ID: 17474152
[TBL] [Abstract][Full Text] [Related]
2. Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration.
Duffy SM; Cruse G; Cockerill SL; Brightling CE; Bradding P
Eur J Immunol; 2008 Sep; 38(9):2548-56. PubMed ID: 18792407
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
[TBL] [Abstract][Full Text] [Related]
4. Functional KCa3.1 K+ channels are required for human lung mast cell migration.
Cruse G; Duffy SM; Brightling CE; Bradding P
Thorax; 2006 Oct; 61(10):880-5. PubMed ID: 16809411
[TBL] [Abstract][Full Text] [Related]
5. A defect in KCa3.1 channel activity limits the ability of CD8
Chimote AA; Balajthy A; Arnold MJ; Newton HS; Hajdu P; Qualtieri J; Wise-Draper T; Conforti L
Sci Signal; 2018 Apr; 11(527):. PubMed ID: 29692361
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of adenosine on degranulation of human cultured mast cells upon cross-linking of Fc epsilon RI.
Suzuki H; Takei M; Nakahata T; Fukamachi H
Biochem Biophys Res Commun; 1998 Jan; 242(3):697-702. PubMed ID: 9464280
[TBL] [Abstract][Full Text] [Related]
7. Beta2-adrenoceptor regulation of the K+ channel iKCa1 in human mast cells.
Duffy SM; Cruse G; Lawley WJ; Bradding P
FASEB J; 2005 Jun; 19(8):1006-8. PubMed ID: 15817638
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
Feoktistov I; Biaggioni I
Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection induced by adenosine A1 receptor agonists in a cardiac cell ischemia model involves cooperative activation of adenosine A2A and A2B receptors by endogenous adenosine.
Urmaliya VB; Church JE; Coupar IM; Rose'Meyer RB; Pouton CW; White PJ
J Cardiovasc Pharmacol; 2009 May; 53(5):424-33. PubMed ID: 19333129
[TBL] [Abstract][Full Text] [Related]
11. Adenosine activates Gα
Arizmendi N; Kulka M
Biochem Pharmacol; 2018 Oct; 156():157-167. PubMed ID: 30099007
[TBL] [Abstract][Full Text] [Related]
12. The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patients.
Visentin S; De Nuccio C; Bernardo A; Pepponi R; Ferrante A; Minghetti L; Popoli P
J Neurosci; 2013 Sep; 33(39):15388-93. PubMed ID: 24068806
[TBL] [Abstract][Full Text] [Related]
13. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine.
Hein TW; Wang W; Zoghi B; Muthuchamy M; Kuo L
J Mol Cell Cardiol; 2001 Feb; 33(2):271-82. PubMed ID: 11162132
[TBL] [Abstract][Full Text] [Related]
14. Regionally selective cardiovascular responses to adenosine A
Cooper SL; Wragg ES; Pannucci P; Soave M; Hill SJ; Woolard J
FASEB J; 2022 Apr; 36(4):e22214. PubMed ID: 35230706
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.
Garção P; Szabó EC; Wopereis S; Castro AA; Tomé ÂR; Prediger RD; Cunha RA; Agostinho P; Köfalvi A
Br J Pharmacol; 2013 Aug; 169(7):1600-11. PubMed ID: 23638679
[TBL] [Abstract][Full Text] [Related]
16. Orai/CRACM1 and KCa3.1 ion channels interact in the human lung mast cell plasma membrane.
Duffy SM; Ashmole I; Smallwood DT; Leyland ML; Bradding P
Cell Commun Signal; 2015 Jul; 13():32. PubMed ID: 26177720
[TBL] [Abstract][Full Text] [Related]
17. The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cells.
Mark Duffy S; Berger P; Cruse G; Yang W; Bolton SJ; Bradding P
J Allergy Clin Immunol; 2004 Jul; 114(1):66-72. PubMed ID: 15241346
[TBL] [Abstract][Full Text] [Related]
18. PKA reduces the rat and human KCa3.1 current, CaM binding, and Ca2+ signaling, which requires Ser332/334 in the CaM-binding C terminus.
Wong R; Schlichter LC
J Neurosci; 2014 Oct; 34(40):13371-83. PubMed ID: 25274816
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability.
Wang J; Huxley VH
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H3094-105. PubMed ID: 16815983
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists.
Yang M; Soohoo D; Soelaiman S; Kalla R; Zablocki J; Chu N; Leung K; Yao L; Diamond I; Belardinelli L; Shryock JC
Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):133-44. PubMed ID: 17310264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
